Despite the rise of self-medication in Greece, its impact is not being fully felt in dermatologicals, as there is a limited range of OTC products available. The majority of sales of products to treat skin conditions derive from non-OTC brands, with these often being sold under the counter.
Consumers remain price sensitive in post-recession Greece, especially when treating minor conditions. Although a number of lines of added value dermatologicals were launched towards the end of the review period their appeal is limited.
While standard dermatologicals saw only steady growth in current value terms in 2019, herbal/traditional dermatologicals saw dynamic growth. This is down to the growing interest among younger generations in using natural alternatives to standard medicines where possible.
With a wide product portfolio and strong brands, such as Daktarin, Regaine and Fungoral, Johnson & Johnson Hellas SA is the leading player in dermatologicals. Regaine dominates hair loss treatments with its value share continuing to grow in 2019 with it now offering products for both men and women following the launch of Regaine Women’s foam earlier in the review period.
Similarly, GSK Consumer Healthcare also offers a large portfolio of dermatologicals, with it adding Pfizer’s Preparation H brand, which leads haemorrhoid treatments, to its range following the decision to combine the two companies’ portfolios. The company’s Fenistil brand dominates topical allergy remedies/antihistamines and is the second biggest brand in dermatologicals overall.
Lavipharm SA retained third place in the rankings in 2019 with it benefiting from the popularity of its Betadine brand, which is accounts for most sales of topical germicidals/antiseptics in Greece. Its low retail price coupled with strong consumer awareness have helped the brand to maintain its dominance, while it also faces little competition.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Greece with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Medicated Skin Care industry in Greece, our research will save you time and money while empowering you to make informed, profitable decisions.
The Medicated Skin Care in Greece market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.